Ezetimibe and Simvastatin

Product NDC
45963-568
11-digit product format
459630568
Labeler code
45963
Product ID
45963-568_ea5eedea-08bf-4180-8119-ed74e6365fae
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ezetimibe and Simvastatin
Dosage form
TABLET
Route
ORAL
Labeler
Actavis Pharma, Inc.
Application
ANDA202968
Marketing category
ANDA
Marketing start
2017-04-26
Marketing end
0000-00-00
Substance
EZETIMIBE; SIMVASTATIN
Active strength
10 mg/1; mg/1
Pharmacologic classes
Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
45963-568-08EA - Each45963-5685699bcfb-8f1b-402f-83a0-6050f90e2b6812017-05-03
45963-568-30EA - Each45963-56898ed4cd3-f3b3-4d78-9dc2-a2676dbf6c6712017-05-03

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
45963-568EZETIMIBE AND SIMVASTATIN TABLET [ACTAVIS PHARMA, INC.]21Legacy NDC20250322_00680bea-d2fb-4362-ba67-e866b732e9ed.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
45963-568-084596305680890 TABLET in 1 BOTTLE (45963-568-08) 90 tablet2017-04-260000-00-00NoNoCurrent
45963-568-304596305683030 TABLET in 1 BOTTLE (45963-568-30) 30 tablet2017-04-260000-00-00NoNoCurrent